Blinded, placebo-controlled trial of antiparasitic drugs for trichinosis myositis

Journal of Infectious Diseases

Volumn 182, Issue 1, 2000, Pages 371-374

  Watt, George ^a   Saisorn, Supachai ^c   Jongsakul, Krisada ^a   Sakolvaree, Yuwaporn ^b   Chaicumpa, Wanpen ^b  

^a ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c Chiangrai Provincial Health Office   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; MEBENDAZOLE; TIABENDAZOLE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE TRANSMISSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; MYOSITIS; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRICHINELLA SPIRALIS; TRICHINOSIS;

ADOLESCENT; ADULT; ANTINEMATODAL AGENTS; DOUBLE-BLIND METHOD; FEMALE; FLUCONAZOLE; HUMANS; MALE; MEBENDAZOLE; MYOSITIS; THIABENDAZOLE; TREATMENT OUTCOME; TRICHINOSIS;

EID: 0033930348     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315645     Document Type: Article

References (14)

1. 1. Horstmann RD, Kern P, Volkmer KJ, Dietrich M. Observations on mebendazole vs. thiabendazole in the treatment of human trichinellosis. Tropenmed Parasitol 1982; 33:191-4.
2. 2. Fourestie V, Bougnoux ME, Ancelle T, et al. Randomized trial of albendazole versus tiabendazole plus flubendazole during an outbreak of human trichinellosis. Parasitol Res 1988; 75:36-41.
3. 3. Zaman V. Trichinosis. In: Weatherall DG, Ledingham JGG, Warrell DA, eds. Oxford textbook of medicine. 3d ed. Oxford, UK: Oxford University Press, 1996:941.
4. 4. Hess JA, Chandrasekar PH, Mortiere M, Molinari JA. Comparative efficacy of ketoconazole and mebendazole in experimental trichinosis. Antimicrob Agents Chemother 1986; 30:953-4.
5. 5. Cabie A, Bouchaud O, Houze S, et al. Albendazole versus thiabendazole as therapy for trichinosis: a retrospective study. Clin Infect Dis 1996; 22: 1033-5.
6. 6. Jongwutiwes S, Chantachum N, Kraivichian P, et al. First outbreak of human trichinellosis caused by Trichinella pseudospiralis. Clin Infect Dis 1998; 26:111-5.
7. 7. Keittivuti A, Keittivuti B. Anthelminthic effects of albendazole, mebendazole and diethylcarbamazine on Trichinella spiralis in mice. J Sci Soc Thailand 1989; 15:49-54.
8. 8. Murrell KD. Trichinosis. In: Strickland GT, ed. Hunter's tropical medicine. Philadelphia: WB Saunders, 1991:756-61.
9. 9. Kociecka W. Intestinal trichinellosis. In: Clinics in tropical medicine and communicable diseases. Philadelphia: WB Saunders, 1986:756-63.
10. 10. Ruangkunaporn Y, Watt G, Karnasuta C, et al. Immunodiagnosis of trichinellosis: efficacy of somatic antigen in early detection of human trichinellosis. Asian Pac J Allergy Immunol 1994; 12:39-42.
11. 11. Pawlowski ZS. Clinical aspects in man. In: Campbell WC, ed. Trichinella and trichinosis. New York: Plenum Press, 1983:367-401.
12. 12. Wang ZQ, Cui J, Wu F, Mao FR, Jin XX. Epidemiological, clinical and serological studies on trichinellosis in Henan Province, China. Acta Trop 1998; 71:255-68.
13. 13. Semple AB, Davies JBM, Kershaw WE, Hill CA. An outbreak of trichinosis in Liverpool in 1953. Br Med J 1954; 1:1002-6.
14. 14. Neyman K, Talarczyk Z. An epidemic of trichinosis at Mosina. Przegl Epidemiol 1961; 15:279-83.